The Tuberous Sclerosis Complex Research Program (TSCRP) is now accepting Pre-Applications for the fiscal year 2022 grant cycle.
Three award mechanisms are available this year:
- Exploration – Hypothesis Development Award (up to $150,000 in direct costs over two years)
- Idea Development Award (up to $500,000 in direct costs over three years)
- Clinical Translational Research Award (up to $1,000,000 in direct costs over three years)
The deadline to submit a Pre-Application Letter of Intent is June 30, 2021 at 5 pm Eastern. A brief summary of the three award mechanisms and submission requirements can be found here.
The TSCRP is part of the Congressionally Directed Medical Research Programs (CDMRPs) at the United States Department of Defense. Please see the TSCRP website for more information on these three funding mechanisms.